Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

For Immediate ReleaseChicago, IL – April 8, 2025 – Stocks in this week’s article are ANI Pharmaceuticals, Inc. ANIP, Expand Energy Corporation EXE, Avista Corp AVA and Contango ORE, Inc. CTGO.Tariff Woes? Play It Safe with 4 Low-Beta Stocks: ANIP, EXE, AVA, CTGOPresident Donald Trump’s recently imposed tariff has rattled the equity market. The action will weigh on the already slowing domestic economy as the tariff will increase prices of both domestic and imported goods, thereby fueling uncertainty.In this context, creating a curated portfolio of low-beta stocks is a prudent strategy. This provides a safeguard against the uncertain market, equipping investors to navigate volatility with greater resilience and foresight.Hence, stocks like ANI Pharmaceuticals, Inc., Expand Energy Corporation, Avista Corp and Contango ORE, Inc. are worth betting on.What Does Beta of a Stock Measure?Beta measures the volatility or risk of a particular asset compared to the market. In other words, beta measures the extent of a security’s price movement relative to the market. In this article, we are considering the S&P 500 as the market.If a stock has a beta of 1, then the price of the stock will move with the market. So, the stock is more volatile than the market if its beta is more than 1. In the same way, the stock is not as volatile as the market if its beta is less than 1.For example, if the market offers a return of 20%, a stock with a beta of 3 will return 60%, which is overwhelming. Similarly, when the market slips 20%, the stock will sink 60%, which is devastating.Here are four of the eight stocks that qualified for the screening:ANI Pharmaceuticals ANI Pharmaceuticals is a well-established, diversified biopharmaceutical company that is highly committed to offering premium quality medicines that are affordable. Investors applauded ANIP for its recent launch of Nitazoxanide Tablets, 500 mg. ANIP is banking on its Generics business, thanks to the launches of new products. For 2025, the stock has seen upward revisions to earnings estimates over the past 30 days.Expand Energy As a leading producer of natural gas, Expand Energy has been banking on exploding demand for clean energy across the world. EXE is on track to meet its $500 million synergy target this year, thanks to a strong focus on integration and effectively carrying out its plans and strategies. Expand Energy, which is driving to lower its breakeven costs, has witnessed upward earnings estimate revisions for 2025 and 2026 over the past seven days.Avista In the United States, Avista is among the leading utilities responsible for very low carbon emissions. To support its growing and large customer base, AVA has set up a solid capital investment program. From the estimated $525 million capital investment in 2025, AVA is planning to grow its investment to $650 million in 2029, securing a rate base growth of 5% to 6%. Notably, over the past 30 days, the company has witnessed upward earnings estimate revisions for 2025.ContangoContango, a gold explorer, is experiencing an increase in net operating cash flows thanks to the commencement of production at Manh Chox`x`h. The company boasted that through the remaining life of the Manh Choh, it will be able to generate higher cash flows, as roughly 30% of the net gold production from the mine for fiscal years 2025 and 2026 will be linked to spot gold prices.You can get the rest of the stocks on this list by signing up now for your two-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Avista Corporation (AVA): Free Stock Analysis Report ANI Pharmaceuticals, Inc. (ANIP): Free Stock Analysis Report Contango ORE, Inc. (CTGO): Free Stock Analysis Report Expand Energy Corporation (EXE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks